Daily SPAC Update – September 3, 2025

by | Sep 3, 2025

Denali Capital + Semnur Pharmaceuticals Deal Vote. Solarius Capital Separate Trading. Dynamix Gets Ether Injection.

Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

MERGER VOTES
DECA – Denali Capital Acquisition Corp + Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. is a clinical-late stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies. Semnur’s lead program, SP-102, is the first non-opioid novel gel formulation administered epidurally in development for patients with moderate to severe chronic radicular pain/sciatica. Semnur Pharmaceuticals, Inc. is headquartered in Palo Alto, California.

SEPARATE WARRANTS/RIGHTS
Sep 05: SOLARIUS CAPITAL ACQUISITION CORP (SOCA)
Sep 03: NMP ACQUISITION CORP (NMP)

OTHER SPAC NEWS
ETHM – DYNAMIX CORP * Stockholder Agreement

NEW SPAC IPOs
Aug 27: KOYN – CSLM Digital Asset Acquisition Corp III, Ltd $200M IPO (+underwriter overallotment: $30M)
Aug 27: MBVI – M3-Brigade Acquisition VI Corp. $300M IPO (+underwriter overallotment: $45M)

SPAC Movers

YESTERDAY’S TOP SPAC GAINERS
7.57% ~ $ 10.51 | IROH – IRON HORSE ACQUISITIONS CORP (Announced)
1.71% ~ $ 11.93 | ATMC – ALPHATIME ACQUISITION CORP (Announced)
1.16% ~ $ 11.31 | NETD – NABORS ENERGY TRANSITION CORP II (Announced)
.33% ~ $ 10.49 | GRAF – GRAF GLOBAL CORP (Pre-Deal)
.33% ~ $ 11.67 | TBMC – TRAILBLAZER MERGER CORP I (Announced)

YESTERDAY’S TOP SPAC LOSERS
-9.84% ~ $ 11.00 | EMCG – EMBRACE CHANGE ACQUISITION CORP (Announced)
-5.49% ~ $ 10.67 | YORK – YORKVILLE ACQUISITION CORP (Announced)
-4.35% ~ $ 11.00 | ALCY – ALCHEMY INVESTMENTS ACQUISITION CORP 1 (Announced)
-2.90% ~ $ 12.30 | DMYY – DMY SQUARED TECHNOLOGY GROUP INC (Pre-Deal)
-1.71% ~ $ 11.50 | HOND – HCM II ACQUISITION CORP (Announced)

LATEST SPAC IPO PERFORMANCE
Aug 27 | $ 10.06 | KOYN – CSLM Digital Asset Acquisition Corp III, Ltd
Aug 27 | $ 10.02 | MBVI – M3-Brigade Acquisition VI Corp.
Aug 21 | $ 10.10 | CEPF – Cantor Equity Partners IV, Inc.
Aug 12 | $ 10.05 | HVMC – Highview Merger Corp.
Aug 12 | $ 9.98 | MKLY – McKinley Acquisition Corp
Aug 08 | $ 10.04 | SSEA – STARRY SEA ACQUISITION CORP
Aug 05 | $ 10.04 | QUMS – Quantumsphere Acquisition Corp

Recent Analysis

Daily SPAC Update – March 25, 2026

Relativity Acquisition (RACY) + Instinct Brothers Deal Vote Today. UY Scuti Extension Vote. Oak Woods Delisting. Haymaker Redemption Agreement.

Daily SPAC Update – March 24, 2026

DeSPAC for Pelican + Greenland Exploration/March GL Expected Today. Goldenstone Extension Approved. Technology & Teleccomunications Deal Vote Set.

Daily SPAC Update – March 20, 2026

Another Quantum DeSPAC as DMY becomes Horizon Quantum. Inflection Point III Increases PIPE. UY Scuti Moves Vote Again. Blue Water IV IPOs for $125 Million.

Daily SPAC Update – March 19, 2026

SPAC IPOs Slow as BHAV Acquisition’s IPO Makes it Only 6 for March. Integrated Wellness Extension and Voyager + Veraxa Biotech Deal Approved. Quartzsea Deal Terminated.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.